Details for Patent: 11,738,044
✉ Email this page to a colleague
Which drugs does patent 11,738,044 protect, and when does it expire?
Patent 11,738,044 protects LOKELMA and is included in one NDA.
This patent has twenty-five patent family members in nineteen countries.
Drugs Protected by US Patent 11,738,044
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | LOKELMA | sodium zirconium cyclosilicate | FOR SUSPENSION;ORAL | 207078-001 | May 18, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF HYPERKALEMIA IN ADULTS | ⤷ Sign Up | ||||
| Astrazeneca | LOKELMA | sodium zirconium cyclosilicate | FOR SUSPENSION;ORAL | 207078-002 | May 18, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF HYPERKALEMIA IN ADULTS | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,738,044
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 106369 | ⤷ Sign Up | |||
| Australia | 2016338753 | ⤷ Sign Up | |||
| Brazil | 112018007189 | ⤷ Sign Up | |||
| Canada | 3000950 | ⤷ Sign Up | |||
| Chile | 2018000916 | ⤷ Sign Up | |||
| China | 108137620 | ⤷ Sign Up | |||
| China | 113143958 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
